血清CA-19-9测定对胰腺癌的诊断价值  

Serum CA -19-9 Level in Pancreatic Carcinoma

作　　者：朱传桂[1] 李永培[2] 丁忠旗[2] 盛强[2] 

机构地区：[1]泰州职业技术学院 [2]泰州市人民医院,江苏泰州225300

出　　处：《泰州职业技术学院学报》2002年第1期39-40,共2页Journal of Taizhou Polytechnic College

摘　　要：目的:寻求胰腺癌的诊断方法。方法:用免疫放射分析法(IRMA)检测血清CA-19-9含量。106例血清CA-19-9含量3700 u/L,进行追踪随访。结果:106例中,胰腺癌66例,结肠癌15例,胆管癌13例,肺癌9例。结论:检测血清CA-19-9含量,有利于胰腺癌的诊断和与结肠癌、胆管癌、肺癌等恶性肿瘤的鉴别。Objective: To look for the method for the diagnosis of pancreatic cancer. Methods: The IRMA method was used to measure the serum CA -19-9 level. 106 patients with the serum CA -19-9 level > 37000u/L were followed up.Results: Among 106 patients,66 were patients with pancreatic cancer, 15 patients with colon cancer, 13 patients with bile duct cancer and 9 patients with lung cancer. Conclusion: The measurement of serum CA -19 - 9 is a helpful mark in diagnosis of pancreatic cancer. It is also valuable in differentiating pancreatic cancer from other malignant tumours,such as colon cancer, bile duct cancer and lung cancer.

关 键 词：诊断价值 胰腺癌 免疫放射分析 CA-19-9 肿瘤诊断 血清检测 

分 类 号：R735.9[医药卫生—肿瘤] R730.4[医药卫生—临床医学]